| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $284.9M | +25.8% |
| Cost of Revenue | $112.5M | +25.5% |
| Gross Profit | $172.3M | +26.0% |
| R&D Expense | $226.1M | +5.1% |
| SG&A Expense | $72.8M | -4.6% |
| Operating Income | -$126.6M | +18.1% |
| Pre-tax Income | -$117.7M | +20.7% |
| Income Tax | -$602K | -102.9% |
| Net Income | -$117.1M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.6M | -0.2% |
| Accounts Receivable | $29.8M | +19.3% |
| Inventory | $34.4M | +18.5% |
| Current Assets | $320.6M | +14.4% |
| Total Assets | $689.0M | +4.8% |
| Current Liabilities | $121.0M | +45.8% |
| Total Liabilities | $127.6M | +30.4% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.8M | +77.9% |
| Investing Cash Flow | -$40.5M | -616.8% |
| Financing Cash Flow | $6.4M | +42.0% |
| +30.9% |
| EPS (Basic) | -$2.84 | +33.2% |
| EPS (Diluted) | -$2.84 | +33.2% |
| Stockholders' Equity |
| $561.4M |
| +0.3% |